The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation-Reference-Cited by-同舟云学术

The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation

Published:2019-03 Issue: Volume:43 Page:29-37
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Saleem Hamza,Kulsoom Abdul U.,Küçükosmanoglu Asli,Houweling Megan,Cornelissen Fleur M.G.,Heiland Dieter H.,Hegi Monika E.,Kouwenhoven Mathilde C.M.,Bailey David,Würdinger Tom,Westerman Bart A.

Funder

Brain Tumor Charity

Dutch Cancer Society

Dutch Brain Tumor Society Stophersentumoren

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference72 articles.

1. De-repression of &em&PDGFRβ&/em& transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients;Akhavan;Cancer Discov.,2013

2. ROS1 amplification mediates resistance to gefitinib in glioblastoma cells;Aljohani;Oncotarget,2015

3. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Comprehensive analysis of kinase inhibitor selectivity;Anastassiadis;Nat. Biotechnol.,2011

4. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015

5. Dominant mechanisms of primary resistance differ from dominant mechanisms of secondary resistance to targeted therapies;Asić;Crit. Rev. Oncol. Hematol.,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induced dual-target rebalance simultaneously enhances efficient therapeutical efficacy in tumors;Cell Death Discovery;2024-05-23

2. Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models;Clinical Cancer Research;2024-05-14

3. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures;Nature Communications;2023-09-28

4. Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults;Frontiers in Oncology;2023-09-13

5. Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks;PLOS Computational Biology;2023-09-05